Explore comprehensive CDMO and CRO services offered by Crystal Pharmatech, supporting end-to-end Anlaytical Testing, Drug Development and Packaging. Crystal Pharmatech enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: Canada, China, U.S.A.
Description: Crystal Pharmatech is a global contract research and development (CRO/CDMO) company specializing in solid-state research and formulation development for small-molecule drugs. Founded in 2010, the company provides integrated services from early-stage developability assessment to clinical trial and commercial manufacturing, with a focus on speeding up drug development through its Mol2Med™ Program. The company has R&D centers and cGMP facilities in the United States, Canada, and China.
